Obstructive sleep apnoea syndrome is a growing health concern, affecting nearly one billion
people worldwide; it is an independent cardiovascular risk factor, associated with incident …

Obstructive sleep apnea (OSA) is an underdiagnosed condition characterized by recurrent
episodes of obstruction of the upper airway leading to sleep fragmentation and intermittent …

The enzyme lipoprotein lipase (LPL), originally identified as the clearing factor lipase,
hydrolyzes triglycerides present in the triglyceride-rich lipoproteins VLDL and chylomicrons …

Recent studies have demonstrated that obstructive sleep apnea (OSA) is associated with the
development and evolution of nonalcoholic fatty liver disease (NAFLD), independent of …

Chronic inflammatory state in obesity causes dysregulation of the endocrine and paracrine
actions of adipocyte-derived factors, which disrupt vascular homeostasis and contribute to …

Obstructive sleep apnea (OSA) is independently associated with death from cardiovascular
diseases, including myocardial infarction and stroke. Myocardial infarction and stroke are …

Sleep quality and sleep disorders affect symptom manifestation and the pathogenesis of
digestive diseases. Sleep is largely regulated by the light–dark cycle and associated …

Obstructive sleep apnoea (OSA) is a very common disorder that affects 10–25% of the
general population. In the past two decades, OSA has emerged as a cardiometabolic risk …

Obstructive sleep apnea (OSA) is a common but largely undiagnosed clinical condition,
which is turning into a serious public health issue. Of note is that its prevalence is gradually …

Lipid metabolism deregulation constitutes the pathogenic basis for the development of
atherosclerosis and justifies a high incidence of cardiovascular-related morbidity and …